{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:55:18Z","timestamp":1791352518703,"version":"4.3.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["110-G7-4"],"award-info":[{"award-number":["110-G7-4"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022871","name":"National Defense Medical Center","doi-asserted-by":"publisher","award":["111-P-12"],"award-info":[{"award-number":["111-P-12"]}],"id":[{"id":"10.13039\/100022871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-11A1-MRCO-08222201"],"award-info":[{"award-number":["NHRI-11A1-MRCO-08222201"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Affairs Bureau, TAIWAN","award":["MND-MAB-D-111081"],"award-info":[{"award-number":["MND-MAB-D-111081"]}]},{"name":"National Science and Technology Council","award":["NSTC 113-2327-B-016-001"],"award-info":[{"award-number":["NSTC 113-2327-B-016-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09973-y","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:01:56Z","timestamp":1727676116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Facile quantitative diagnostic testing for neutralizing antibodies against Chikungunya virus"],"prefix":"10.1186","volume":"24","author":[{"given":"Hui-Chung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Chin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Jiang","family":"Chiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yun","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Cheng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"1","key":"9973_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","volume":"9","author":"K Bartholomeeusen","year":"2023","unstructured":"Bartholomeeusen K, Daniel M, LaBeaud DA, Gasque P, Peeling RW, Stephenson KE, Ng LFP, Ari\u00ebn KK. Chikungunya fever. Nat Rev Dis Primers. 2023;9(1):17.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"9973_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1172\/JCI84417","volume":"127","author":"LA Silva","year":"2017","unstructured":"Silva LA, Dermody TS. Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest. 2017;127(3):737\u201349.","journal-title":"J Clin Invest"},{"issue":"6","key":"9973_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4269\/ajtmh.15-0332","volume":"93","author":"JM Velasco","year":"2015","unstructured":"Velasco JM, Valderama MT, Lopez MN, Chua D Jr., Latog R 2nd, Roque V Jr., Corpuz J, Klungthong C, Rodpradit P, Hussem K, et al. Chikungunya Virus infections among patients with Dengue-Like illness at a Tertiary Care Hospital in the Philippines, 2012\u20132013. Am J Trop Med Hyg. 2015;93(6):1318\u201324.","journal-title":"Am J Trop Med Hyg"},{"issue":"suppl 5","key":"9973_CR4","doi-asserted-by":"publisher","first-page":"S471","DOI":"10.1093\/infdis\/jiw274","volume":"214","author":"BW Johnson","year":"2016","unstructured":"Johnson BW, Russell BJ, Goodman CH. Laboratory diagnosis of Chikungunya Virus infections and Commercial sources for diagnostic assays. J Infect Dis. 2016;214(suppl 5):S471\u20134.","journal-title":"J Infect Dis"},{"issue":"3","key":"9973_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3201\/eid1403.070906","volume":"14","author":"M Panning","year":"2008","unstructured":"Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis. 2008;14(3):416\u201322.","journal-title":"Emerg Infect Dis"},{"key":"9973_CR6","doi-asserted-by":"crossref","unstructured":"Piantadosi A, Kanjilal S. Diagnostic Approach for Arboviral Infections in the United States. J Clin Microbiol 2020, 58(12).","DOI":"10.1128\/JCM.01926-19"},{"key":"9973_CR7","doi-asserted-by":"crossref","unstructured":"Allen SW, Ribeiro Dos Santos G, Paul KK, Paul R, Rahman MZ, Alam MS, Rahman M, Al-Amin HM, Vanhomwegen J, Weaver SC et al. Results of a nationally representative seroprevalence survey of Chikungunya virus in Bangladesh. J Infect Dis 2024.","DOI":"10.1093\/infdis\/jiae335"},{"issue":"10394","key":"9973_CR8","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","volume":"401","author":"M Schneider","year":"2023","unstructured":"Schneider M, Narciso-Abraham M, Hadl S, McMahon R, Toepfer S, Fuchs U, Hochreiter R, Bitzer A, Kosulin K, Larcher-Senn J, et al. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2023;401(10394):2138\u201347.","journal-title":"Lancet"},{"issue":"50","key":"9973_CR9","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1016\/j.vaccine.2018.10.033","volume":"37","author":"GN Milligan","year":"2019","unstructured":"Milligan GN, Schnierle BS, McAuley AJ, Beasley DWC. Defining a correlate of protection for Chikungunya virus vaccines. Vaccine. 2019;37(50):7427\u201336.","journal-title":"Vaccine"},{"issue":"1","key":"9973_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.chom.2015.06.009","volume":"18","author":"SA Smith","year":"2015","unstructured":"Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, et al. Isolation and characterization of Broad and Ultrapotent Human Monoclonal Antibodies with therapeutic activity against Chikungunya Virus. Cell Host Microbe. 2015;18(1):86\u201395.","journal-title":"Cell Host Microbe"},{"key":"9973_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-1-4939-3618-2_25","volume":"1426","author":"NA Azami","year":"2016","unstructured":"Azami NA, Moi ML, Takasaki T. Neutralization assay for Chikungunya Virus infection: Plaque reduction neutralization test. Methods Mol Biol. 2016;1426:273\u201382.","journal-title":"Methods Mol Biol"},{"key":"9973_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/1743-422X-10-235","volume":"10","author":"S Gl\u00e4sker","year":"2013","unstructured":"Gl\u00e4sker S, Lulla A, Lulla V, Couderc T, Drexler JF, Liljestr\u00f6m P, Lecuit M, Drosten C, Merits A, K\u00fcmmerer BM. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout. Virol J. 2013;10:235.","journal-title":"Virol J"},{"issue":"6","key":"9973_CR13","doi-asserted-by":"publisher","first-page":"e83527","DOI":"10.1172\/jci.insight.83527","volume":"2","author":"P Roques","year":"2017","unstructured":"Roques P, Ljungberg K, K\u00fcmmerer BM, Gosse L, Dereuddre-Bosquet N, Tchitchek N, Halleng\u00e4rd D, Garc\u00eda-Arriaza J, Meinke A, Esteban M, et al. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight. 2017;2(6):e83527.","journal-title":"JCI Insight"},{"issue":"2","key":"9973_CR14","doi-asserted-by":"publisher","first-page":"e0192110","DOI":"10.1371\/journal.pone.0192110","volume":"13","author":"VA Mugabe","year":"2018","unstructured":"Mugabe VA, Ali S, Chelene I, Monteiro VO, Guiliche O, Muianga AF, Mula F, Ant\u00f3nio V, Chongo I, Oludele J, et al. Evidence for chikungunya and dengue transmission in Quelimane, Mozambique: results from an investigation of a potential outbreak of Chikungunya virus. PLoS ONE. 2018;13(2):e0192110.","journal-title":"PLoS ONE"},{"issue":"5","key":"9973_CR15","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JVI.03453-13","volume":"88","author":"D Halleng\u00e4rd","year":"2014","unstructured":"Halleng\u00e4rd D, Kakoulidou M, Lulla A, K\u00fcmmerer BM, Johansson DX, Mutso M, Lulla V, Fazakerley JK, Roques P, Le Grand R, et al. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice. J Virol. 2014;88(5):2858\u201366.","journal-title":"J Virol"},{"issue":"6","key":"9973_CR16","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1128\/JVI.03418-13","volume":"88","author":"J Garc\u00eda-Arriaza","year":"2014","unstructured":"Garc\u00eda-Arriaza J, Cepeda V, Halleng\u00e4rd D, Sorzano C, K\u00fcmmerer BM, Liljestr\u00f6m P, Esteban M. A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection. J Virol. 2014;88(6):3527\u201347.","journal-title":"J Virol"},{"key":"9973_CR17","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Camacho C, Kim YC, Blight J, Lazaro Moreli M, Montoya-Diaz E, Huiskonen JT, K\u00fcmmerer BM, Reyes-Sandoval A. Assessment of Immunogenicity and Neutralisation Efficacy of viral-vectored vaccines against Chikungunya Virus. Viruses 2019, 11(4).","DOI":"10.3390\/v11040322"},{"issue":"1","key":"9973_CR18","doi-asserted-by":"publisher","first-page":"21076","DOI":"10.1038\/s41598-020-78009-7","volume":"10","author":"I Szurgot","year":"2020","unstructured":"Szurgot I, Ljungberg K, K\u00fcmmerer BM, Liljestr\u00f6m P. Infectious RNA vaccine protects mice against Chikungunya virus infection. Sci Rep. 2020;10(1):21076.","journal-title":"Sci Rep"},{"issue":"1","key":"9973_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12275-020-9384-0","volume":"58","author":"WC Chung","year":"2020","unstructured":"Chung WC, Hwang KY, Kang SJ, Kim JO, Song MJ. Development of a neutralization assay based on the pseudotyped Chikungunya virus of a Korean isolate. J Microbiol. 2020;58(1):46\u201353.","journal-title":"J Microbiol"},{"key":"9973_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jviromet.2014.02.001","volume":"201","author":"C Weber","year":"2014","unstructured":"Weber C, K\u00f6nig R, Niedrig M, Emmerich P, Schnierle BS. A neutralization assay for Chikungunya virus infections in a multiplex format. J Virol Methods. 2014;201:7\u201312.","journal-title":"J Virol Methods"},{"issue":"1","key":"9973_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00253-022-12280-8","volume":"107","author":"SK Tsai","year":"2023","unstructured":"Tsai SK, Hsu YL, Chiao DJ, Shu PY, Lin HT, Chang SF, Lin HC, Huang SH, Wang CH, Hsiung CC, et al. Antigenicity and immunogenicity of Chikungunya virus-like particles from mosquito cells. Appl Microbiol Biotechnol. 2023;107(1):219\u201332.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"9973_CR22","doi-asserted-by":"publisher","first-page":"9844","DOI":"10.1038\/s41598-022-13230-0","volume":"12","author":"C Su","year":"2022","unstructured":"Su C, Ding K, Xu J, Wu J, Liu J, Shen J, Zhou H, Liu H. Preparation and application of chikungunya pseudovirus containing double reporter genes. Sci Rep. 2022;12(1):9844.","journal-title":"Sci Rep"},{"key":"9973_CR23","doi-asserted-by":"crossref","unstructured":"Henss L, Yue C, Kandler J, Faddy HM, Simmons G, Panning M, Lewis-Ximenez LL, Baylis SA, Schnierle BS. Establishment of an Alphavirus-Specific neutralization assay to Distinguish infections with different members of the Semliki Forest complex. Viruses 2019, 11(1).","DOI":"10.3390\/v11010082"},{"issue":"10","key":"9973_CR24","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/infdis\/jiz658","volume":"221","author":"L Henss","year":"2020","unstructured":"Henss L, Yue C, Von Rhein C, Tschismarov R, Lewis-Ximenez LL, D\u00f6lle A, Baylis SA, Schnierle BS. Analysis of Humoral Immune responses in Chikungunya Virus (CHIKV)-Infected patients and individuals vaccinated with a candidate CHIKV Vaccine. J Infect Dis. 2020;221(10):1713\u201323.","journal-title":"J Infect Dis"},{"issue":"6","key":"9973_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4269\/ajtmh.2010.10-0279","volume":"83","author":"SM Ayu","year":"2010","unstructured":"Ayu SM, Lai LR, Chan YF, Hatim A, Hairi NN, Ayob A, Sam IC. Seroprevalence survey of Chikungunya virus in Bagan Panchor, Malaysia. Am J Trop Med Hyg. 2010;83(6):1245\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"9973_CR26","doi-asserted-by":"publisher","first-page":"e0006163","DOI":"10.1371\/journal.pntd.0006163","volume":"11","author":"LW Ang","year":"2017","unstructured":"Ang LW, Kam YW, Lin C, Krishnan PU, Tay J, Ng LC, James L, Lee VJM, Goh KT, Ng LFP, et al. Seroprevalence of antibodies against Chikungunya virus in Singapore resident adult population. PLoS Negl Trop Dis. 2017;11(12):e0006163.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"9973_CR27","doi-asserted-by":"publisher","first-page":"e0003764","DOI":"10.1371\/journal.pntd.0003764","volume":"9","author":"IK Yoon","year":"2015","unstructured":"Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, et al. High rate of subclinical Chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines. PLoS Negl Trop Dis. 2015;9(5):e0003764.","journal-title":"PLoS Negl Trop Dis"},{"key":"9973_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fpubh.2018.00186","volume":"6","author":"KL Barr","year":"2018","unstructured":"Barr KL, Khan E, Farooqi JQ, Imtiaz K, Prakoso D, Malik F, Lednicky JA, Long MT. Evidence of Chikungunya Virus Disease in Pakistan since 2015 with patients demonstrating involvement of the Central Nervous System. Front Public Health. 2018;6:186.","journal-title":"Front Public Health"},{"issue":"5","key":"9973_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1473-3099(15)70043-5","volume":"15","author":"K Ramsauer","year":"2015","unstructured":"Ramsauer K, Schwameis M, Firbas C, M\u00fcllner M, Putnak RJ, Thomas SJ, Despr\u00e8s P, Tauber E, Jilma B, Tangy F. Immunogenicity, safety, and tolerability of a recombinant measles-virus-based Chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. Lancet Infect Dis. 2015;15(5):519\u201327.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"9973_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.4269\/ajtmh.15-0696","volume":"94","author":"AM Bosco-Lauth","year":"2016","unstructured":"Bosco-Lauth AM, Nemeth NM, Kohler DJ, Bowen RA. Viremia in north American mammals and birds after experimental infection with Chikungunya viruses. Am J Trop Med Hyg. 2016;94(3):504\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"9973_CR31","doi-asserted-by":"publisher","first-page":"e0485422","DOI":"10.1128\/spectrum.04854-22","volume":"11","author":"HC Lin","year":"2023","unstructured":"Lin HC, Chiao DJ, Shu PY, Lin HT, Hsiung CC, Lin CC, Kuo SC. Development of a Novel Chikungunya Virus-Like Replicon Particle for Rapid Quantification and Screening of Neutralizing Antibodies and antivirals. Microbiol Spectr. 2023;11(2):e0485422.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"9973_CR32","doi-asserted-by":"publisher","first-page":"12321","DOI":"10.1038\/s41598-021-91830-y","volume":"11","author":"HC Lin","year":"2021","unstructured":"Lin HC, Chiao DJ, Lin CC, Kuo SC. Facile method for delivering chikungunya viral replicons into mosquitoes and mammalian cells. Sci Rep. 2021;11(1):12321.","journal-title":"Sci Rep"},{"issue":"8","key":"9973_CR33","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3201\/eid1408.071304","volume":"14","author":"PY Shu","year":"2008","unstructured":"Shu PY, Yang CF, Su CL, Chen CY, Chang SF, Tsai KH, Cheng CH, Huang JH. Two imported chikungunya cases, Taiwan. Emerg Infect Dis. 2008;14(8):1326\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"9973_CR34","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1128\/JCM.41.6.2408-2416.2003","volume":"41","author":"PY Shu","year":"2003","unstructured":"Shu PY, Chang SF, Kuo YC, Yueh YY, Chien LJ, Sue CL, Lin TH, Huang JH. Development of group- and serotype-specific one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue virus. J Clin Microbiol. 2003;41(6):2408\u201316.","journal-title":"J Clin Microbiol"},{"key":"9973_CR35","doi-asserted-by":"crossref","unstructured":"Klasse PJ. Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives. Adv Biol 2014, 2014.","DOI":"10.1155\/2014\/157895"},{"key":"9973_CR36","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.26633\/RPSP.2017.62","volume":"41","author":"PM De Salazar","year":"2017","unstructured":"De Salazar PM, Valadere AM, Goodman CH, Johnson BW. Evaluation of three commercially-available Chikungunya virus immunoglobulin G immunoassays. Rev Panam Salud Publica. 2017;41:e62.","journal-title":"Rev Panam Salud Publica"},{"key":"9973_CR37","doi-asserted-by":"crossref","unstructured":"Honda T, Gomi S, Yamane D, Yasui F, Yamamoto T, Munakata T, Itoh Y, Ogasawara K, Sanada T, Yamaji K et al. Development and Characterization of a Highly Sensitive NanoLuciferase-Based Immunoprecipitation System for the Detection of Anti-Influenza Virus HA Antibodies. mSphere 2021, 6(3).","DOI":"10.1128\/mSphere.01342-20"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09973-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09973-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09973-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T18:53:25Z","timestamp":1727722405000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09973-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9973"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09973-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4786216\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study on clinical human serum samples was reviewed and approved by the Institutional Review Board (IRB 109105) under the auspices of the Taiwan Center for Disease Control. Patient consent was waived due to dis-linkage of all data from patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1076"}}